2 Australian stocks to buy with $5,000 after the market selloff

Analysts are tipping these shares to deliver big returns for investors.

| More on:
A woman stands at her desk looking a her phone with a panoramic view of the harbour bridge in the windows behind her with work colleagues in the background.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Yesterday's market selloff was very disappointing for investors. But it is worth remembering that every cloud has a silver lining.

On this occasion, the silver lining is that investors can now pick up shares at a discount to what they were going for just last week.

With that in mind, if you have $5,000 to invest in the share market, then it could be worth checking out the Australian stocks listed below that analysts rate as buys. Here's what they are saying about them:

Pilbara Minerals Ltd (ASX: PLS)

The first Australian stock that could be a buy with your $5,000 after the selloff is Pilbara Minerals. It is one of the world's leading lithium miners and the owner of the world class Pilgangoora Operation in the Pilbara.

Bell Potter is likely to see yesterday's decline (and 12 months of share price weakness) as a buying opportunity for investors. The broker currently has a buy rating and $3.00 price target on its shares. This suggests that potential upside of 35% for investors from current levels.

Its analysts think that lithium prices could improve meaningfully in the near term given its forecast for shortfalls from 2026. They said:

PLS operates a low-cost asset in a tier one jurisdiction, is diversifying through the lithium value chain, and provides a clean exposure to global lithium fundamentals and sentiment. While we expect lithium prices to remain volatile, we hold a robust EV-demand driven long-term market outlook. We believe higher prices are required to incentivise new sources of supply to moderate our forecast market shortfalls from 2026-27.

ResMed Inc. (ASX: RMD)

This sleep disorder treatment company could be another Australian stock to buy with your $5,000 after the market selloff.

Goldman Sachs certainly believes this is the case. In response to its second quarter update last week, the broker has retained its buy rating with an improved price target of $49.00. This implies potential upside of 26% for investors over the next 12 months.

The broker believes that the company's positive growth outlook means that its shares deserve to trade on better multiples. It said:

Our Buy recommendation on RMD is premised on (1) Ongoing robust new patient growth for CPAP therapy despite the market entry of GLP-1 drugs to treat OSA, (2) Further RMD market share gains, building on its #1 global market position, (3) Expansion of the OSA market in regions outside of the US. We believe the stock's current trading multiple is unjustified based on its growth outlook

Motley Fool contributor James Mickleboro has positions in ResMed. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group and ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

An angry man struggles with a broken zip in his jacket
Broker Notes

Zip shares have slumped 26% in 2025. Time to consider buying?

Should investors buy now or wait til later with this stock?

Read more »

Two smiling work colleagues discuss an investment or business plan at their office.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A young man pointing up looking amazed, indicating a surging share price movement for an ASX company
Broker Notes

These ASX 200 shares could rise 30% to 40%

Analysts are tipping these shares to generate big returns over the next 12 months.

Read more »

A female worker in a hard hat smiles in an oil field.
Broker Notes

Buy BHP and this ASX 200 share next week

Here are a couple of shares that Bell Potter rate highly this month.

Read more »

A young man sits at his desk working on his laptop with a big smile on his face due to his ASX shares going up and in particular the Computershare share price
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A man slumps crankily over his morning coffee as it pours with rain outside.
Broker Notes

Why did this $1 billion ASX 300 stock just crash 10%?

This stock isn't having a good finish to the week. What's going on?

Read more »

A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
Blue Chip Shares

Is it too late to buy this $33 billion ASX 200 stock?

Do analysts think this popular stock can deliver good returns for investors? Let's find out.

Read more »

a man sits at his desk wearing a business shirt and tie and has a hearty laugh at something on his mobile phone.
Broker Notes

5 ASX All Ords shares upgraded to 'strong buy' consensus ratings

Brokers upgraded their ratings on these ASX All Ords stocks last month.

Read more »